(Q57826741)
Statements
Recombinant gp160 as a therapeutic vaccine for HIV-infection: results of a large randomized, controlled trial. European Multinational IMMUNO AIDS Vaccine Study Group (English)
F D Goebel
J W Mannhalter
M M Eibl
P J Grob
V de Gruttola
P D Griffiths
V Erfle
M Kunschak